ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/07/2026
Back to search
Official data from USPTO
CC CELULARITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
01/08/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
06/27/2018
Registration date
08/11/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2020
Last transaction
01/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/06/2018
First use in commerce
12/06/2018
Drawing code
5
Owner type
11
Owner location
SINGAPORE, SG
Examiner
FALK,JONATHAN ROBERT
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a purple tilted "C" next to a green backwards tilted "C" forming an infinity symbol above the word "CELULARITY" in purple.
Holders and representatives
Holders
CELENIV PTE. LTD.
CELULARITY INC.
Celularity, Inc.
Celularity, Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
bioengineered cells for use in scientificlaboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientificlaboratory and medical research
Class 5
Cells and biological preparations intended for medical and clinical usebloodstem cellsumbilical cord cellsumbilical cord bloodplacental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical useplacental-derived natural killer cellsplacental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical useplacental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
Publications
History of USPTO decisions and trademark events.
54 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/11/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/09/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/22/2020
GNRT
NON-FINAL ACTION E-MAILED
05/22/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/22/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2020
IUAF
USE AMENDMENT FILED
04/28/2020
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2019
NOAC
CORRECTED NOA E-MAILED
11/09/2019
EX2G
SOU EXTENSION 2 GRANTED
11/08/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
11/08/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/08/2019
EXT2
SOU EXTENSION 2 FILED
10/29/2019
DRRR
DIVISIONAL REQUEST RECEIVED
10/29/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/29/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/29/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/30/2019
EX1G
SOU EXTENSION 1 GRANTED
05/28/2019
EXT1
SOU EXTENSION 1 FILED
05/28/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/28/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/25/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/30/2018
PUBO
PUBLISHED FOR OPPOSITION
10/30/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2018
ALIE
ASSIGNED TO LIE
09/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/04/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/30/2018
GNFR
FINAL REFUSAL E-MAILED
08/30/2018
CNFR
FINAL REFUSAL WRITTEN
08/30/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/24/2018
GNRT
NON-FINAL ACTION E-MAILED
07/24/2018
CNRT
NON-FINAL ACTION WRITTEN
07/24/2018
DOCK
ASSIGNED TO EXAMINER
07/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2018
NWAP
NEW APPLICATION ENTERED
06/30/2018
Continuous trademark protection
Get notified about every new filing that threatens CC CELULARITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.